Professional Continuous Glucose Monitoring Reveals Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Treated with Oral Antidiabetics
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2016; 40(1):155-157.
DOI: 10.2337/dc16-2215.
View
2.
Wolk R, Gami A, Garcia-Touchard A, Somers V
. Sleep and cardiovascular disease. Curr Probl Cardiol. 2005; 30(12):625-62.
DOI: 10.1016/j.cpcardiol.2005.07.002.
View
3.
Goff Jr D, Gerstein H, Ginsberg H, Cushman W, Margolis K, Byington R
. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007; 99(12A):4i-20i.
DOI: 10.1016/j.amjcard.2007.03.002.
View
4.
Kim Y, Cho B, Kim W, Kim S, Jung I, Sin W
. Frequency and Severity of Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with a Sulfonylurea-Based Regimen at University-Affiliated Hospitals in Korea: The Naturalistic Evaluation of Hypoglycemic Events in Diabetic Subjects Study. Korean J Fam Med. 2019; 40(4):212-219.
PMC: 6669385.
DOI: 10.4082/kjfm.18.0051.
View
5.
Gais S, Born J, Peters A, Schultes B, Heindl B, Fehm H
. Hypoglycemia counterregulation during sleep. Sleep. 2003; 26(1):55-9.
DOI: 10.1093/sleep/26.1.55.
View